LYN Antikörper (N-Term)
Kurzübersicht für LYN Antikörper (N-Term) (ABIN2304718)
Target
Alle LYN Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Human, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
-
Produktmerkmale
- LYN, NT (FLJ26625, JTK8, Tyrosine Protein Kinase Lyn, v-yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog)
-
Aufreinigung
- Purified by Protein G affinity chromatography.
-
Immunogen
- Synthetic peptide selected from the N-terminal region of human LYN (KLH).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- LYN (V-Yes-1 Yamaguchi Sarcoma Viral Related Oncogene Homolog (LYN))
-
Andere Bezeichnung
- LYN
-
UniProt
- P07948
-
Pathways
- Fc-epsilon Rezeptor Signalübertragung, Hormone Transport, Response to Growth Hormone Stimulus, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, CXCR4-mediated Signaling Events, Thromboxane A2 Receptor Signaling, Integrin Complex, BCR Signaling
Target
-